Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magalie Haissaguerre

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Biologie Aujourd'Hui|March 30, 2016
[Role of the mTOR pathway in the central regulation of energy balance]Magalie Haissaguerre, Daniela Cota
Annales D'Endocrinologie|January 25, 2022
What an endocrinologist should know for patients receiving lithium therapyMagalie Haissaguerre, Marie-Christine Vantyghem
Molecular and Cellular Endocrinology|August 12, 2014
Influence of mTOR in energy and metabolic homeostasisMagalie Haissaguerre, Nicolas Saucisse, Daniela Cota
European Journal of Endocrinology|October 16, 2018
Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?Marine Ollivier, Magalie Haissaguerre, Amandine Ferriere, et al.
World Journal of Surgery|June 29, 2022
Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-AnalysisDamien Bouriez, Caroline Gronnier, Magalie Haissaguerre, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 7, 2023
Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidismGhoufrane Tlili, Charles Mesguich, Delphine Gaye, et al.
European Journal of Endocrinology|January 31, 2020
MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinionJacques Young, Magalie Haissaguerre, Oceana Viera-Pinto, et al.
Frontiers in Pharmacology|June 6, 2018
NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of LeptinMagalie Haissaguerre, Amandine Ferriere, Samantha Clark, et al.
Annales D'Endocrinologie|October 24, 2022
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Initial work-up for thyroid nodulesChristine Do Cao, Magalie Haissaguerre, Charlotte Lussey-Lepoutre, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 6: Syndromic primary hyperparathyroidismAbdallah Al-Salameh, Magalie Haissaguerre, Christophe Tresallet, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Biologie Aujourd'Hui|March 30, 2016
[Role of the mTOR pathway in the central regulation of energy balance]Magalie Haissaguerre, Daniela Cota
Annales D'Endocrinologie|January 25, 2022
What an endocrinologist should know for patients receiving lithium therapyMagalie Haissaguerre, Marie-Christine Vantyghem
Molecular and Cellular Endocrinology|August 12, 2014
Influence of mTOR in energy and metabolic homeostasisMagalie Haissaguerre, Nicolas Saucisse, Daniela Cota
European Journal of Endocrinology|October 16, 2018
Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?Marine Ollivier, Magalie Haissaguerre, Amandine Ferriere, et al.
World Journal of Surgery|June 29, 2022
Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-AnalysisDamien Bouriez, Caroline Gronnier, Magalie Haissaguerre, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 7, 2023
Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidismGhoufrane Tlili, Charles Mesguich, Delphine Gaye, et al.
European Journal of Endocrinology|January 31, 2020
MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinionJacques Young, Magalie Haissaguerre, Oceana Viera-Pinto, et al.
Frontiers in Pharmacology|June 6, 2018
NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of LeptinMagalie Haissaguerre, Amandine Ferriere, Samantha Clark, et al.
Annales D'Endocrinologie|October 24, 2022
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Initial work-up for thyroid nodulesChristine Do Cao, Magalie Haissaguerre, Charlotte Lussey-Lepoutre, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 6: Syndromic primary hyperparathyroidismAbdallah Al-Salameh, Magalie Haissaguerre, Christophe Tresallet, et al.
Pageof 6